热门资讯> 正文
Crispr董事乔治购买5150万美元股票
2025-07-18 22:08
- Crispr Therapeutics (NASDAQ:CRSP) has disclosed a $51.5 million stock purchase by board director Simeon George in an SEC filing.
- Crispr surged as much as 21% on Friday, marking its biggest intraday gain since February, after. The stock is now up around 58.4% year-to-date.
More on CRISPR Therapeutics
- Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)
- Crispr Therapeutics: Face The Harsh Reality Instead Of Waiting (Rating Downgrade)
- Crispr Therapeutics: Betting On A One-Shot Future
- CRISPR delays early-stage readout for heart disease therapy
- Crispr extends gains for the seventh consecutive trading day
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
